Clinical Trial Update: A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Fluzoparil in combination with temozolomide for recurrent glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Fluzoparil (Fluzoparil)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Glioblastoma | Phase 2 | Status: UNKNOWN